Editas Medicine Inc (EDIT:NASDAQ)

$2.13 0.02 (0.95%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Editas Medicine Inc (EDIT:NASDAQ) News Sources

Editas Medicine to Participate in Upcoming Investor Conferences

Markets Insider

external link

Regenerative Medicine Market Analysis by Key Drivers, Top Players, Forecast, Growth Rate, Constraints, Future Trends, Events, And Challenges Until 2029

PharmiWeb

external link

Periods may trigger pain for many who have sickle cell disease

EurekAlert!

external link
EDIT stock
EDIT stock price
EDIT stock price today
EDIT stock prediction
EDIT earnings date
EDIT news
EDIT price
EDIT share
EDIT share price
EDIT shares
EDIT ceo
EDIT premarket
$EDIT
EDIT ticker
EDIT after hours
EDIT stock
EDIT stock price
EDIT stock price today
EDIT stock prediction
EDIT earnings date
EDIT news
EDIT price
EDIT share
EDIT share price
EDIT shares
EDIT ceo
EDIT premarket
$EDIT
EDIT ticker
EDIT after hours

Editas Medicine Inc (EDIT:NASDAQ) FAQs

toggle

What is the current price of Editas Medicine Inc (EDIT:NASDAQ)?

The current price of Editas Medicine Inc (EDIT:NASDAQ) is $2.13.


toggle

Editas Medicine Inc (EDIT:NASDAQ) absolute price change since previous trading day?

The absolute price change of Editas Medicine Inc (EDIT:NASDAQ) since the previous trading day is $0.02.


toggle

Editas Medicine Inc (EDIT:NASDAQ) percentage price change since previous trading day?

The percentage price change of Editas Medicine Inc (EDIT:NASDAQ) since the previous trading day is 0.95%.


toggle

What is This Week's average sentiment score for Editas Medicine Inc (EDIT:NASDAQ)?

This Week's average sentiment score for Editas Medicine Inc (EDIT:NASDAQ) is 79 out of 100.


toggle

What is This Week's average sentiment for Editas Medicine Inc (EDIT:NASDAQ)?

This Week's sentiment for Editas Medicine Inc (EDIT:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.